Manni A, Badger B, Lynch J, Demers L
Department of Medicine, Milton S. Hershey Medical Center, Pennsylvania State University, Hershey 17033.
Breast Cancer Res Treat. 1991 Jan-Feb;17(3):187-96. doi: 10.1007/BF01806368.
The present experiments were designed to evaluate the polyamine involvement in hormonal actions on proliferation and receptor content of neoplastic tissue (hormone-responsive breast cancer) as well as on growth of normal endocrine target tissue (uterus) in the same animals. Administration of estradiol and perphenazine (to stimulate endogenous prolactin release) stimulated N-nitrosomethyl-urea (NMU)-induced rat mammary tumor growth following ovariectomy-induced tumor regression. Such hormonal activation of breast cancer growth was completely abolished by treatment with alpha-difluoromethyl-ornithine (DFMO), a specific irreversible inhibitor of ornithine decarboxylase, which lowered tumor content of polyamines. The growth inhibitory effect of DFMO was partially reversible by exogenous putrescine administration. In contrast, the rise in cytosolic content of progesterone receptors induced by hormonal treatment was not affected by suppression of tumor polyamine levels by DFMO. Similarly, DFMO administration failed to influence the hormone-induced increase in uterine weight in the same animals. Thus, our data suggest selectivity of polyamine involvement in hormone actions, which, in our experimental system, seems to be restricted to the endocrine control of neoplastic cell proliferation.
本实验旨在评估多胺在激素对肿瘤组织(激素反应性乳腺癌)增殖和受体含量以及同一动物正常内分泌靶组织(子宫)生长的作用中的参与情况。在卵巢切除诱导肿瘤消退后,给予雌二醇和奋乃静(以刺激内源性催乳素释放)可刺激N-亚硝基甲基脲(NMU)诱导的大鼠乳腺肿瘤生长。乳腺癌生长的这种激素激活作用被α-二氟甲基鸟氨酸(DFMO)完全消除,DFMO是鸟氨酸脱羧酶的一种特异性不可逆抑制剂,它降低了肿瘤中的多胺含量。通过外源性给予腐胺,DFMO的生长抑制作用部分可逆。相比之下,激素治疗诱导的孕酮受体胞质含量升高不受DFMO抑制肿瘤多胺水平的影响。同样,给予DFMO未能影响同一动物中激素诱导的子宫重量增加。因此,我们的数据表明多胺参与激素作用具有选择性,在我们实验系统中,这似乎仅限于肿瘤细胞增殖的内分泌控制。